Tumor Biology

, Volume 36, Issue 2, pp 557–558 | Cite as

Questions about XY Wen et al. entitled “Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis”

Research Commentary

Abstract

XY Wen et al. published an article entitled “Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis” in Tumor Biology last year. The investigators demonstrated that high MMP2 expression was associated with poor prognosis in osteosarcoma. After reading these articles, we have some questions about the data extraction and processing in the meta-analysis.

Keywords

Matrix metalloproteinase 2 Osteosarcoma Meta-analysis 

References

  1. 1.
    Wen X et al. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis. Tumour Biol. 2014;35(1):845–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Guo HB, Xiao T. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis". Tumour Biol. 2014;35(5):5053.CrossRefPubMedGoogle Scholar
  3. 3.
    Kushlinsky NE, Solovyov YN, Babkina IV, Gershtein ES, Bulicheva IV. Matrix metalloproteinases 2,7, and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors. Bull Exp Biol Med. 2010;149:233–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Sun C, Zang Y, Yang L, Liu H, Li S. Association of malignant osteoblastoma prognosis with midkine, survivin and MMP-2 expression [article in Chinese]. Med Recapitulate. 2010;16:3833–4.Google Scholar
  5. 5.
    Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K, Ishiguro N. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol. 2006;28:33–42.PubMedGoogle Scholar
  6. 6.
    Li W, Ye Z, Yang D, Tao H. The expression of vascular endothelial growth factor, matrix metalloproteinases 2,9 in osteosarcoma [article in Chinese]. Zhejiang Med J. 2006;28:691–4.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Shandong UniversityJinanChina

Personalised recommendations